Oncology

Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells, broadly categorized into solid tumors that form masses in organs and tissues, and hematologic malignancies that affect blood-forming tissues and circulating blood cells. Cosmo Bio USA offers an extensive portfolio of oncology research products designed to advance understanding of the fundamental molecular events that drive both types of cancer. The collection includes validated antibodies, ELISA kits, and recombinant proteins that enable researchers to investigate the critical pathways underlying cancer development, including genetic mutations, dysregulated cell signaling, altered metabolism, and disrupted cell cycle control. These research tools support the study of how normal cells transform into malignant ones, how tumors evade immune surveillance, develop resistance to cell death, and acquire the ability to invade surrounding tissues and metastasize to distant sites.  

Cosmo Bio USA delivers an integrated oncology research toolkit that connects molecular alterations with functional outcomes, empowering scientists to accelerate discovery in cancer biology, develop better diagnostic biomarkers, and translate fundamental research into improved therapeutic strategies for patients with both solid and liquid tumors.  Browse the complete portfolio of Oncology research tools below.